Who we are
The Barcelona Institute for Global Health, ISGlobal, is the fruit of an innovative alliance between “la Caixa”, academic institutions and government bodies to contribute to the efforts undertaken by the international community to address the challenges in global health.
ISGlobal is a consolidated hub of excellence in research that has grown out of work first started in the world of health care by the Hospital Clínic and the Parc de Salut MAR and in the academic sphere by the University of Barcelona and Pompeu Fabra University.
The pivotal mechanism of its work model is the transfer of knowledge generated by scientific research to practice, a task undertaken by the institute’s Education and Policy and Global Development departments.
Its ultimate goal is to help close the gaps in health disparities between and within different regions of the world.
Our vision
Our vision is to be a world class research and translation centre in Global Health working towards a world in which all people can enjoy health
Our Mission
ISGlobal’s mission is to improve global health and promote health equity through excellence in research and the translation and application of knowledge
The team
Dr. Alberto García-Basteiro
Project Co-applicant
Assistant Research Professor at the Barcelona Institute for Global Health, ISGlobal in Barcelona, Spain and the coordinator of the TB research unit at the Centro de Investigação em Saúde de Manhiça (CISM), Mozambique.
He trained as a physician at the University of Santiago de Compostela (USC) in Spain and completed his residency in Preventative Medicine and Public Health at Hospital Clinic, University of Barcelona. Dr Garcia-Basteiro received his Master´s Degree in Epidemiology from the London School of Hygiene and Tropical Medicine (LSHTM) and later completed his PhD under the Erasmus Mundus Transglobal Health Joint Doctorate Programme, which was awarded by the University of Amsterdam (Amsterdam Institute for Global Health and Development, AIGHD) and the University of Barcelona (ISGlobal). Dr Garcia-Basteiro joined ISGlobal in 2012 and is a lecturer on the MSc of Global Health at the University of Barcelona.
Dr Garcia-Basteiro has participated in many research projects and clinical trials focusing on poverty-related diseases, mostly in Central America and Africa. Currently, he is coordinating several large epidemiological studies, numerous evaluations of new diagnostic tools and various clinical drug trials in the field of tuberculosis. Dr. Garcia-Basteiro’s scientific interest focuses on assessing and understanding the burden of TB in Africa, particularly Mozambique, in the characterization of tuberculous at the microbiological, clinical and social level and in the development of new diagnostic tools and treatments.
Since the beginning of his academic career, Dr Garcia-Basteiro has published more than 100 peer reviewed articles in prestigious biomedical journals and has been invited as guest speaker at various important international conferences. He has received recognition and prizes for his work including the “Young Lecture” distinction (awarded by the Spanish Association of Respiratory Medicine and Thoracic Surgery), The Enrique Najera Young Epidemiologist Award (from the Spanish Association of Epidemiology) and The 2017 Union Young Scientific Prize for the best young researcher in tuberculosis (awarded by the International Union against Tuberculosis and Lung Disease IUTLD).
Contact: alberto.garcia-basteiro@isglobal.org
Belén Saavedra Cervera (MSc)
Has a degree in Pharmacy from the Complutense University of Madrid (UCM) and a specialization in Clinical Microbiology and Parasitology.
She holds an MSc in Control of Infectious Diseases from the London School of Hygiene and Tropical Medicine. In 2016, she joined the Tuberculosis Research Group at the Centro de Investigação em Saúde de Manhiça (Mozambique) and at the Barcelona Institute for Global Health (ISGlobal) as a Tuberculosis Researcher and Coordinator of the Laboratory Area.
At the moment, she is also pursuing her PhD in Molecular Epidemiology of Tuberculosis.
Partners
Information about Consortium
